The Honorable Merrick B. Garland
Attorney General of the United States
U.S. Department of Justice
950 Pennsylvania Avenue, NW
Washington, DC 20530-0001
Dear Mr. Attorney General:
On behalf of the American Medical Association (AMA) and the undersigned national medical
specialty societies, we are writing to ask your assistance to resolve a harmful interpretation of
Section 3204 of Public Law 115-271, the Substance Use Disorder Prevention that Promotes
Opioid Recovery and Treatment for Patients and Communities Act of 2018 (SUPPORT Act).
Section 3204 of the SUPPORT Act amended the Controlled Substances Act to provide that
pharmacies may dispense controlled substances for the maintenance or detoxification of opioid
use disorder directly to practitioners for injection or implantation in patients. The legislative
intent and purpose of Section 3204 was to increase access to implantable and injectable
prescription formulations of medications to treat opioid use disorder (MOUD).
Read full letter here
